glp 1 approved for kids Weight loss drugs now Opinion | If Kids Need

Cases 10 , 74957501 (2022)

Manufacturers are facing increasing pressure to develop efficient, cost-effective production methods to meet the surging demand

Schedule comprehensive 12-month assessments

Critical Price Increases (December 2025 - March 2026): Ingredient Price Increase Primary Use Thiocolchicide 106% Muscle relaxant Glycerin 64% Solvent, excipient Nimesulide 53% Pain relief Deflazacort 50% Steroid Clobetasol Propionate 47% Skin treatment Amoxicillin Trihydrate 45% Antibiotic Paracetamol 26% Fever, pain Diclofenac Sodium 25-30% Anti-inflammatory Ciprofloxacin 20-30% Antibiotic Solvents (IPA, Acetone) 20-30% Manufacturing Multiple Factors Driving Crisis: Rupee depreciation against US dollar Petroleum-linked solvent costs (oil at $115/barrel) Container shortages and vessel delays from China Opportunistic pricing by some suppliers Industry Response: The Federation of Pharma Entrepreneurs has formally requested NPPA intervention, seeking permission for price hikes under DPCO 2013 Para 19

And so its very attractive to people like addiction researchers